Mapping the Clinical Trial Landscape for Cannabinoids in Neurology: A Registry-Based Systematic Review
This systematic review of cannabinoid clinical trials neurological disorders highlights research focused on Multiple Sclerosis, Fibromyalgia, and Parkinson's Disease. It reveals challenges due to inconsistent protocols and dosing across studies. The…
When it comes to Parkinson’s, hope is not a plan, but urgent action is
Parkinsons disease cannabis treatment requires urgent action rather than passive hope. Patients must understand the distinction between evidence-based therapies and unproven claims. This approach helps manage symptoms effectively while setting realistic…
Cannabinoids and cognition in Parkinson’s disease: Insights from animal models and emerging clinical evidence.
Cannabinoids and cognition in Parkinson's disease are increasingly studied due to the endocannabinoid system's role in neural circuits affected by PD. Animal models show promising neuroprotective and cognition-preserving effects of cannabinoids. However,…
5 Essential Breakthroughs in Cannabis Neuromodulation
Imagine a world where a simple plant could revolutionize the way we treat some of the most challenging health issues, from anxiety and depression to Alzheimer's and Parkinson's disease. Cannabis, a plant often surrounded by controversy, is…